
Hanmi Pharmaceutical has categorized its key stakeholders into 6 groups, referencing its business model, business activities, and the current state of sustainable management among global pharmaceutical companies. From the planning stage for sustainability, we communicate with stakeholders to share their concerns and our responses through the Sustainability Report and other channels. Going forward, Hanmi Pharmaceutical will actively incorporate the opinions of its various stakeholders into management activities to achieve sustainable management and growth.
1. Employees and Other Internal Stakeholders | ||
|---|---|---|
Key Concerns | Company's Response | Communication Channels |
Entities directly performing business activities | ㆍVarious welfare benefits support | ㆍInternal Intranet |
2. Business Partners | ||
Key Concerns | Company's Response | Communication Channels |
Entities providing products and services necessary for business activities | ㆍFair Trade-based Compliance Program | ㆍConstant communication channels |
3. Customers | ||
Key Concerns | Company's Response | Communication Channels |
Physicians/Pharmacists Patients, etc. | ㆍOperation of Pharmacovigilance System | ㆍVOC collection |
4. Shareholders and Investors | ||
Key Concerns | Company's Response | Communication Channels |
Creation of financial and non-financial performance resulting | ㆍShareholder Meetings | ㆍShareholder Meetings |
5. Government and Policy Institutions/Organizations | ||
Key Concerns | Company's Response | Communication Channels |
Promote sound development of the industry through regulations and policies | ㆍ Operation of compliance systems | ㆍPolicy discussions with various institutions and |
6. Local Community, NGOs | ||
Key Concerns | Company's Response | Communication Channels |
Entities sharing social influence with Hanmi Pharmaceutical | ㆍParticipation in local community social contribution projects | ㆍVOC collection |